Oncoloxía médica
Servizo
Harvard Medical School
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Harvard Medical School (5)
2023
-
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort
Journal of Clinical Medicine, Vol. 12, Núm. 1
2019
2018
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways)
Clinical Microbiology and Infection, Vol. 24, pp. S41-S52
-
Management of unresectable, locally advanced pancreatic adenocarcinoma
Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 113-118
2009
-
Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart
Circulation Research, Vol. 105, Núm. 11, pp. 1128-1140